BRIDGER MANAGEMENT, LLC - Q3 2015 holdings

$1.47 Billion is the total value of BRIDGER MANAGEMENT, LLC's 37 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 56.8% .

 Value Shares↓ Weighting
TEVA NewTEVA PHARMACEUTICAL INDS LTDadr$107,519,0001,904,346
+100.0%
7.33%
MDCO SellMEDICINES CO$93,617,000
+31.4%
2,466,205
-1.0%
6.38%
+183.3%
POST SellPOST HLDGS INC$85,639,000
-4.7%
1,449,045
-13.1%
5.84%
+105.5%
AET NewAETNA INC NEW$78,600,000718,401
+100.0%
5.36%
UNH BuyUNITEDHEALTH GROUP INC$73,496,000
+28.2%
633,535
+34.9%
5.01%
+176.7%
MGM BuyMGM RESORTS INTERNATIONAL$65,444,000
+96.3%
3,547,076
+94.2%
4.46%
+323.5%
LH SellLABORATORY CORP AMER HLDGS$64,809,000
-17.7%
597,487
-8.1%
4.42%
+77.4%
CNC BuyCENTENE CORP DEL$63,750,000
+113.1%
1,175,551
+215.9%
4.35%
+359.6%
ALNY BuyALNYLAM PHARMACEUTICALS INC$57,248,000
-23.4%
712,389
+14.2%
3.90%
+65.1%
HCA SellHCA HOLDINGS INC$56,458,000
-22.2%
729,813
-8.7%
3.85%
+67.9%
PODD BuyINSULET CORP$56,117,000
+0.3%
2,165,850
+20.0%
3.83%
+116.3%
WCG BuyWELLCARE HEALTH PLANS INC$54,934,000
+58.3%
637,428
+55.8%
3.75%
+241.3%
IRWD BuyIRONWOOD PHARMACEUTICALS INC$49,482,000
+63.5%
4,748,776
+89.2%
3.38%
+252.7%
KYTH  KYTHERA BIOPHARMACEUTICALS I$48,065,000
-0.4%
641,0360.0%3.28%
+114.7%
CHTR  CHARTER COMMUNICATIONS INC Dcl a new$44,635,000
+2.7%
253,8220.0%3.04%
+121.4%
T107PS NewWRIGHT MED GROUP INC$43,799,0002,083,679
+100.0%
2.99%
VRSN  VERISIGN INC$43,429,000
+14.3%
615,4940.0%2.96%
+146.6%
FB SellFACEBOOK INCcl a$42,649,000
-13.5%
474,409
-17.5%
2.91%
+86.5%
AGO SellASSURED GUARANTY LTD$35,947,000
-36.2%
1,437,876
-38.8%
2.45%
+37.5%
SGMS SellSCIENTIFIC GAMES CORPcl a$31,565,000
-43.8%
3,020,580
-16.4%
2.15%
+21.2%
TGTX BuyTG THERAPEUTICS INC$30,783,000
+20.7%
3,053,916
+98.6%
2.10%
+160.2%
PFSI SellPENNYMAC FINL SVCS INCcl a$28,417,000
-14.2%
1,776,073
-2.8%
1.94%
+85.1%
EXAS  EXACT SCIENCES CORP$27,720,000
-39.5%
1,540,8410.0%1.89%
+30.5%
ATRA BuyATARA BIOTHERAPEUTICS INC$23,090,000
-12.7%
734,418
+46.5%
1.58%
+88.4%
BCC SellBOISE CASCADE CO DEL$22,807,000
-63.0%
904,341
-46.2%
1.56%
-20.2%
LBRDA BuyLIBERTY BROADBAND CORP$22,422,000
+27.3%
435,892
+26.1%
1.53%
+174.5%
GRUB NewGRUBHUB INC$20,711,000850,900
+100.0%
1.41%
TROV BuyTROVAGENE INC$18,723,000
-41.5%
3,290,587
+4.4%
1.28%
+26.3%
DYAX BuyDYAX CORP$14,306,000
+3.2%
749,396
+43.2%
0.98%
+122.8%
LXRX BuyLEXICON PHARMACEUTICALS INC$13,880,000
+564.4%
1,292,368
+398.1%
0.95%
+1334.8%
CMRX NewCHIMERIX INC$11,757,000307,782
+100.0%
0.80%
SPNE NewSEASPINE HLDGS CORP$10,023,000618,684
+100.0%
0.68%
ELGX NewENDOLOGIX INC$8,281,000675,421
+100.0%
0.56%
MCRB NewSERES THERAPEUTICS INC$5,971,000201,447
+100.0%
0.41%
MPC SellMARATHON PETE CORP$5,138,000
-91.4%
110,890
-90.3%
0.35%
-81.5%
BYD NewBOYD GAMING CORP$4,557,000279,554
+100.0%
0.31%
NVLS  NIVALIS THERAPEUTICS INC$381,000
-15.7%
33,1590.0%0.03%
+85.7%
RGDXQ ExitRESPONSE GENETICS INC$0-6,000,000
-100.0%
-0.06%
BKFS ExitBLACK KNIGHT FINL SVCS INCcl a$0-215,700
-100.0%
-0.21%
SGYPQ ExitSYNERGY PHARMACEUTICALS DEL$0-847,094
-100.0%
-0.22%
AMRI ExitALBANY MOLECULAR RESH INC$0-558,818
-100.0%
-0.36%
CCJ ExitCAMECO CORP$0-813,586
-100.0%
-0.37%
AMLP ExitALPS ETF TRcall$0-1,000,000
-100.0%
-0.49%
REGN ExitREGENERON PHARMACEUTICALS$0-54,132
-100.0%
-0.87%
LLY ExitLILLY ELI & CO$0-349,591
-100.0%
-0.92%
HUM ExitHUMANA INC$0-168,809
-100.0%
-1.02%
MNKKQ ExitMALLINCKRODT PUB LTD CO$0-399,932
-100.0%
-1.49%
ZTS ExitZOETIS INCcl a$0-1,125,778
-100.0%
-1.72%
CI ExitCIGNA CORPORATION$0-336,429
-100.0%
-1.72%
KAR ExitKAR AUCTION SVCS INC$0-1,475,611
-100.0%
-1.74%
AGN ExitALLERGAN PLC$0-207,322
-100.0%
-1.99%
CAH ExitCARDINAL HEALTH INC$0-780,380
-100.0%
-2.06%
SPY ExitSPDR S&P 500 ETF TRcall$0-7,000,000
-100.0%
-45.57%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-11-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VERISIGN INC40Q1 20235.2%
TEVA PHARMACEUTICAL INDS LTD40Q3 20237.3%
MORGAN STANLEY35Q3 202311.8%
ALNYLAM PHARMACEUTICALS INC34Q3 20214.9%
POST HLDGS INC33Q4 20226.1%
TG THERAPEUTICS INC33Q3 20213.8%
CHARTER COMMUNICATIONS INC N30Q3 20237.2%
ATARA BIOTHERAPEUTICS INC29Q4 20216.4%
GODADDY INC28Q3 20238.9%
CENTENE CORP DEL28Q3 20226.2%

View BRIDGER MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
BRIDGER MANAGEMENT, LLC Q3 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Surrozen, Inc./DESold outFebruary 14, 202200.0%
Atara Biotherapeutics, Inc.February 16, 20211,524,7601.8%
Dicerna Pharmaceuticals IncFebruary 14, 20201,981,6332.9%
TG THERAPEUTICS, INC.February 14, 20201,907,4921.9%
CHIMERIX INCSold outFebruary 14, 201700.0%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold outFebruary 14, 201700.0%
SeaSpine Holdings CorpSold outFebruary 14, 201700.0%
Trovagene, Inc.Sold outFebruary 14, 201700.0%
ARROWHEAD RESEARCH CORPSold outFebruary 16, 201600.0%
PENNYMAC FINANCIAL SERVICES, INC.Sold outFebruary 16, 201600.0%

View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14

View BRIDGER MANAGEMENT, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1466170000.0 != 1466169000.0)

Export BRIDGER MANAGEMENT, LLC's holdings